Literature DB >> 24293967

Preoperative radiotherapy in carcinoma rectum.

Vishnu Prasad Nelamangala Ramakrishnaiah1, Cecil Thankachan Thomas, Elangovan Sundar, Kanipakapatnam Satyanarayana Reddy, Srinivasan Krishnamachari.   

Abstract

The present study was undertaken to address the various concerns that has limited the use of preoperative radiotherapy in rectal cancer in our institution. All patients diagnosed as having carcinoma rectum between August 2005 and July 2007 were included in the study. Group 1 patients consisted of those presenting with T2, T3 and T4 who received preoperative radiation of 25 Gy. Group 2 consisted of those with T4 tumours, who received Long course radiotherapy. Complication of radiation like dermatitis, enteritis and proctitis were noted. Before surgery CT scan and TRUS were repeated. In the postoperative period a record of abdominal, perineal wound complications and other complications were noted. The results were compared with a similar group of patients who did not receive preoperative radiotherapy. There were 21 patients (12males) with a mean age of 48.4 years (Range 18-70) in the radiotherapy group. Sixteen patients received short course (25 Gy) and five patients received long course of preoperative radiotherapy. Fourteen patients underwent definitive surgery in the form of abdominoperineal resection (APR) or anterior resection (AR). In the non-RT group there were 17 patients (8 males) with a mean age of 50.2 year. Fourteen patients underwent definitive surgery like APR (11) and AR (3). In the RT group CT scan and TRUS failed show any significant downsizing or down staging of tumour. In the RT group, incidence of acute skin toxicity was 23.8 % (5/21), all were seen in those who received long course of radiotherapy (Group 2). Grade 2 or 3 lower G I symptoms occurred in 3 (18.6 %) patients of Group 1 and 1(20 %) patient of group 2. There was higher incidence of perineal wound complication in the RT group (19.0 % vs 5.9 %). Preoperative long course of radiotherapy may be associated with high rates of dermatitis and perineal wound infection. Short course may be associated with lower G I toxicity.

Entities:  

Keywords:  Chemotherapy; Radiotherapy; Rectal cancer; Toxicity

Year:  2012        PMID: 24293967      PMCID: PMC3521550          DOI: 10.1007/s13193-012-0181-z

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  16 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer.

Authors:  O Glehen; O Chapet; M Adham; J C Nemoz; J P Gerard
Journal:  Br J Surg       Date:  2003-08       Impact factor: 6.939

3.  Preoperative radiotherapy in operable rectal cancer.

Authors:  A Horn; J F Halvorsen; O Dahl
Journal:  Dis Colon Rectum       Date:  1990-10       Impact factor: 4.585

4.  Early effect of external beam radiation therapy on the anal sphincter: a study using anal manometry and transrectal ultrasound.

Authors:  E H Birnbaum; Z Dreznik; R J Myerson; D L Lacey; R D Fry; I J Kodner; J W Fleshman
Journal:  Dis Colon Rectum       Date:  1992-08       Impact factor: 4.585

5.  Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.

Authors:  Stephen R Smalley; Jacqueline K Benedetti; Stephen K Williamson; John M Robertson; Norman C Estes; Tracy Maher; Barbara Fisher; Tyvin A Rich; James A Martenson; John W Kugler; Al B Benson; Daniel G Haller; Robert J Mayer; James N Atkins; Christine Cripps; John Pedersen; Phillip O Periman; Michael S Tanaka; Cynthia G Leichman; John S Macdonald
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

6.  Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party.

Authors: 
Journal:  Lancet       Date:  1996-12-14       Impact factor: 79.321

Review 7.  Preoperative staging of rectal cancer.

Authors:  H Kwok; I P Bissett; G L Hill
Journal:  Int J Colorectal Dis       Date:  2000-02       Impact factor: 2.571

Review 8.  Advances in radiotherapy in operable rectal cancer.

Authors:  Aravind Suppiah; John E Hartley; John R T Monson
Journal:  Dig Surg       Date:  2009-06-03       Impact factor: 2.588

9.  The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Colorectal Cancer Study Group.

Authors:  B Cedermark; H Johansson; L E Rutqvist; N Wilking
Journal:  Cancer       Date:  1995-05-01       Impact factor: 6.860

10.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Authors:  David Sebag-Montefiore; Richard J Stephens; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Phil Quirke; Jean Couture; Catherine de Metz; Arthur Sun Myint; Eric Bessell; Gareth Griffiths; Lindsay C Thompson; Mahesh Parmar
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.